RecruitingNCT05578105
Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan
Studying Autoimmune polyendocrinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Taiwan University Hospital
- Principal Investigator
- Shyang-Rong Shih, MD, PhDNational Taiwan University Hospital
- Intervention
- no intervention(other)
- Enrollment
- 650 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- National Taiwan University Hospital, Taipei, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05578105 on ClinicalTrials.govOther trials for Autoimmune polyendocrinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07202598Randomized Stepped Wedge Study of Emapalumab in APECED EnteritisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNCT07516886Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical ProstatectomyLithuanian University of Health Sciences
- RECRUITINGPHASE2NCT05398809Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia AreataNational Institute of Allergy and Infectious Diseases (NIAID)